Bellevue Group’s Krystal Biotech KRYS Stock Holding History

Bellevue Group’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$124M	Buy	481,785 +71,462	+17%	+$19M	2.96%	10
2025 Q4	$101M	Buy	410,323 +409,011	+31,175%	+$86.1M	1.92%	16
2025 Q3	$232K	Buy	1,312 +62	+5%	+$9.28K	﹤0.01%	132
2025 Q2	$172K	Sell	1,250 -1,400	-53%	-$206K	﹤0.01%	129
2025 Q1	$478K	Sell	2,650 -2,397	-47%	-$403K	0.01%	117
2024 Q4	$791K	Buy	5,047 +268	+6%	+$47.5K	0.02%	122
2024 Q3	$870K	Buy	4,779 +581	+14%	+$112K	0.01%	122
2024 Q2	$771K	Sell	4,198 -612	-13%	-$103K	0.01%	123
2024 Q1	$856K	Sell	4,810 -3,190	-40%	-$443K	0.01%	124
2023 Q4	$992K	Sell	8,000 -4,500	-36%	-$499K	0.02%	122
2023 Q3	$1.45M	Sell	12,500 -5,500	-31%	-$671K	0.02%	117
2023 Q2	$2.11M	Sell	18,000 -300	-2%	-$30.6K	0.03%	113
2023 Q1	$1.47M	Hold	18,300	–	–	0.02%	121
2022 Q4	$1.45M	Hold	18,300	–	–	0.02%	129
2022 Q3	$1.28M	Buy	18,300 +4,900	+37%	+$354K	0.02%	131
2022 Q2	$880K	Sell	13,400 -400	-3%	-$24.9K	0.01%	138
2022 Q1	$918K	Sell	13,800 -200	-1%	-$12.5K	0.01%	151
2021 Q4	$979K	Buy	+14,000	New	+$815K	0.01%	156

Other funds holding KRYS

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return